Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Nov 5, 2010

Premium

Genstruct has appointed Arnold Levine to its board of directors.

Currently, Levine is a professor at the Institute for Advanced Study and leads the Simons Center for Systems Biology at IAS. He has received several awards for his scientific contributions, including his work in establishing p53 as a tumor suppressor.

He has also served as president and CEO of Rockefeller University in New York City, and has been a faculty member in the biochemistry department at Princeton University and a professor in the school of medicine at the State University of New York.

Levine is a graduate of SUNY and earned a PhD in microbiology from the University of Pennsylvania School of Medicine. He holds honorary degrees from Rider University, the University of Medicine and Dentistry of New Jersey, the Weizmann Institute of Science, and the University Pierre and Marie Curie in Paris, among other institutions.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.